ERBB2 and invasive ductal breast carcinoma: The immunohistochemistry (IHC) breast panel showed poorly differentiated invasive ductal carcinoma (Grade III, Ki67 50%, negative Allred score (0/8), human epidermal growth factor receptor 2-negative (HER2-negative) (0/3)).